• helpdesk@Lucintel.com
  • |
  • +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Hematology Diagnostic Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


the future of the hematology diagnostic market looks promising with opportunities in hospitals and diagnostic labs. The global hematology diagnostic market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major drivers for this market are development of technologically advanced hematology analyzers, increasing usage of flow cytometry in hematology testing, and development of high-sensitivity point-of-care hematology analyzers.

A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global hematology diagnostic market report, please download the report brochure.
 
 

 
In this market, consumables is the largest product of hematology diagnostic, whereas hospitals is the largest end user. Growth in various segments of the hematology diagnostic market are given below:

 
 


The study includes trends and forecast for the global hematology diagnostic market by product, test, end user, and region as follows:

By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Instrument
  • Consumables

By Test [Value ($ Million) shipment analysis for 2014 – 2025]:
  • CBC
    • Hemoglobin
    • Hematocrit
    • RBC
  • WBC
  • Reticulocytes
  • Platelet Function
  • CRP
  • Neutrophil Function
  • Bone Marrow
  • DPG 
 
By End User [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Hospitals
  • Diagnostic Labs
  • Others

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • North America
    • United States
    • Canada 
    • Mexico
  • Europe
    • United Kingdom
    • Spain
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • The Rest of the World
    • Brazil
 

Some of the hematology diagnostic companies profiled in this report include Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Boule Diagnostics, Horiba, Mindray Medical, Nihon Kohden Corporation, Roche Diagnostics, Siemens Healthcare, and Sysmex Corporation.

Lucintel forecasts that consumables will remain the largest product segment over the forecast period due to rise in diagnosis of blood disorders and other infections and increasing test volume owing to rising awareness and early detection.

Within this market, hospitals will remain the largest end user segment over the forecast period due to high patient influx in hospitals and a growing number of registered hospitals across the globe.

North America will remain the largest region over the forecast period due to technological advancements in instruments, ease of usage, and favorable reimbursement scenario.




 
Features of the Global Hematology Diagnostic Market
 
  • Market Size Estimates: Global hematology diagnostic market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global hematology diagnostic market size by various segments, such as product, test, and end user in terms of value.
  • Regional Analysis: Global hematology diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different product, test, end user, and region for the global hematology diagnostic market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global hematology diagnostic market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.



 
This report answers following key questions
 
Q.1 What are some of the most promising potential, high-growth opportunities for the global hematology diagnostic market by product (instrument and consumables),  test (CBC (hemoglobin, hematocrit, and RBC), WBC, reticulocytes, platelet function, CRP, neutrophil function, bone marrow, and DPG), end user (hospitals, diagnostic labs, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global hematology diagnostic market?
Q.5 What are the business risks and threats to the global hematology diagnostic market?
Q.6 What are the emerging trends in this hematology diagnostic market and the reasons behind them?
Q.7 What are some changing demands of customers in this hematology diagnostic market?
Q.8 What are the new developments in this hematology diagnostic market? Which companies are leading these developments?
Q.9 Who are the major players in this hematology diagnostic market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this hematology diagnostic market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global hematology diagnostic market?

 



Report Scope


Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates)
2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Instrument and Consumables),  Test (CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG), and End User (Hospitals, Diagnostic Labs, and Others)

Regional Scope

North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)

Customization 10% Customization without Any Additional Cost
 

 

Table of Contents


1. Executive Summary

2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Hematology Diagnostic Market Trends and Forecast
3.3: Global Hematology Diagnostic Market by Product 
3.3.1: Instrument
3.3.2: Comsumables 
3.4: Global Hematology Diagnostic Market by Test
3.4.1: CBC 
3.4.1.1: Hemoglobin
3.4.1.2: Hematocrit
3.4.1.3: RBC
3.4.2: WBC
3.4.3: Reticulocytes
3.4.4: Platelet Function
3.4.5: CRP
3.4.6: Neutrophil Function
3.4.7: Bone Marrow
3.4.8: DPG
3.5: Global Hematology Diagnostic Market by End User
3.5.1: Hospitals
3.5.2: Diagnostic Labs
3.5.3: Others

4. Market Trends and Forecast Analysis by Region
4.1: Global Hematology Diagnostic Market by Region
4.2: North American Hematology Diagnostic Market
4.2.1: Market by Product: Instrument and Consumables 
4.2.2: Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG 
4.2.3: Market by End User: Hospitals, Diagnostic Labs, and Others
4.2.4: The United States Hematology Diagnostic Market
4.2.5: The Canadian Hematology Diagnostic Market
4.2.6: The Mexican Hematology Diagnostic Market
4.3: European Hematology Diagnostic Market
4.3.1: Market by Product: Instrument and Consumables 
4.3.2: Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG 
4.3.3: Market by End User: Hospitals, Diagnostic Labs, and Others
4.3.4: The United Kingdom Hematology Diagnostic Market
4.3.5: The Spanish Hematology Diagnostic Market
4.3.6: The German Hematology Diagnostic Market
4.3.7: The French Hematology Diagnostic Market
4.4: APAC Hematology Diagnostic Market
4.4.1: Market by Product: Instrument and Consumables 
4.4.2: Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG 
4.4.3: Market by End User: Hospitals, Diagnostic Labs, and Others
4.4.4: The Chinese Hematology Diagnostic Market
4.4.5: The Indian Hematology Diagnostic Market
4.4.6: The Japanese Hematology Diagnostic Market
4.5: ROW Hematology Diagnostic Market
4.5.1: Market by Product: Instrument and Consumables 
4.5.2: Market by Test: CBC (Hemoglobin, Hematocrit, and RBC), WBC, Reticulocytes, Platelet Function, CRP, Neutrophil Function, Bone Marrow, and DPG 
4.5.3: Market by End User: Hospitals, Diagnostic Labs, and Others
4.5.5: Brazilian Hematology Diagnostic Market

5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis

6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Hematology Diagnostic Market by Product 
7.1.2: Growth Opportunities for the Global Hematology Diagnostic Market by Test
7.1.3: Growth Opportunities for the Global Hematology Diagnostic Market by End User
7.1.4: Growth Opportunities for the Global Hematology Diagnostic Market by Region
7.2: Emerging Trends in the Global Hematology Diagnostic Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Hematology Diagnostic Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hematology Diagnostic  Market
7.3.4: Certification and Licensing

8. Company Profiles of Leading Players
8.1: Abbott Laboratories
8.2: Beckman Coulter
8.3: Bio-Rad Laboratories
8.4: Boule Diagnostics
8.5: Horiba
8.6: Mindray Medical
8.7: Nihon Kohden Corporation
8.8: Roche Diagnostics
8.9: Siemens Healthcare
8.10: Sysmex Corporation 
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Hematology Diagnostic Market: Trends, Forecast and Competitive Analysis Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Below is a brief summary of the primary interviews that were conducted by job function for this report.
 

 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.